Alyssa Farah Griffin, a former White House communications director during the Trump administration who is now a CNN political commentator, voluntarily met with federal prosecutors in recent weeks, sitting for a formal interview as part of the ongoing special counsel probe related to January 6 and the former president's efforts to overturn the 2020 election, according to multiple sources familiar with the matter.

By Brendan O'Brien, Rich McKay (Reuters) -Torrential downpours pounded the U.S. Northeast on Monday, threatening catastrophic flooding across the region,

This accusation comes after xQc and IShowSpeed playfully trolled each other, and also engaged in a discussion about xQc's ex-girlfriend, Adept

Jill Duggar claimed that her parents made $18 million after doing 21 seasons on television but failed to give a single penny to her and her siblings

Two helicopters zoomed through the starlit skies before producing spotlights over a Las Vegas desert and U2 frontman Bono, who kneeled to ground while singing “Vertigo.”

Former President Barack Obama will sit down with CNN's Chief International Anchor Christiane Amanpour for an exclusive in-depth conversation about the state of democracy that will air June 22 at 10 p.m. ET.

Few films have broken out like Cord Jefferson's “American Fiction” has at the Toronto International Film Festival."

Ukraine's quest for US-made F-16 fighter jets received a big boost over the weekend when US President Joe Biden gave his backing for Kyiv's pilots to be trained to fly them.

A treatment for acute migraines has been approved for NHS use for the first time, with experts saying the move could be a “step-change” for thousands of people who suffer from the condition. The National Institute for Health and Care Excellence (Nice) said its final draft guidance on Rimegepant “addresses the high unmet need for treatment options for acute migraine”. Rimegepant, also known as Vydura and made by Pfizer, will be available to adults who have tried at least two triptans – medication usually given to tackle headaches or migraines – but found they did not work well enough. It can also be administered to those who are not able to take triptans or have an intolerance, or patients who have tried nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol. Helen Knight, director of medicines evaluation at Nice, said: “Migraine is a condition described in comments to Nice from carers and people with migraine as an invisible disability that affects all aspects of life including work, education, finances, mental health, social activities and family. “Today’s final draft guidance addresses the high unmet need for treatment options for acute migraine, once again demonstrating our ability to ensure clinically and cost-effective medicines are available to those who need them as quickly as possible.” Rimegepant is taken as a wafer, which dissolves under the tongue and works by stopping the release of a protein around the brain called calcitonin gene-related peptide. In July, the medicine was recommended as an option for preventing episodic migraines in adults who have at least four and fewer than 15 attacks per month if “at least” three other treatments have not worked. This is the first and only Nice-recommended medicine that can help alleviate the misery of acute migraines, and may be considered a step-change in treatment Helen Knight, Nice Under the latest guidance, it will also be used to relieve symptoms of a migraine, which can include pain, nausea and sensitivity to light, but also painless symptoms such as temporary visual disturbances known as “aura”, which Nice said “is not well managed with existing treatments”. The recommendation is expected to benefit about 13,000 people. Ms Knight added: “This is the first and only Nice-recommended medicine that can help alleviate the misery of acute migraines, and may be considered a step-change in treatment.” Migraine is an incredibly misunderstood condition that can have a significant impact on all areas of life, including ability to work, maintain relationships and mental health Robert Music, The Migraine Trust Robert Music, chief executive of The Migraine Trust, said the Nice guidance “provides people with migraine valuable options to help reduce the pain and length of a migraine attack”. “It brings new hope,” he added. “It will especially benefit those who have not found a treatment that works, those who get debilitating side effects – including medicine overuse headache – from them, and those with cardiovascular disease who cannot take existing treatments. “Migraine is an incredibly misunderstood condition that can have a significant impact on all areas of life, including ability to work, maintain relationships and mental health.” Read More NHS winter resilience fund announced by Government NHS reliance on paper notes ‘stopping trusts from realising full potential’ Recession fears as UK economy shrinks by more than expected in shock decline Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live

The fate of Wagner private mercenary group founder Yevgeny Prigozhin was unclear on Wednesday evening, after his name was listed among passengers of a plane that crashed north of Moscow.

There was double world sprint joy for Noah Lyles in Budapest on Friday while the second fastest women's 200m run in history saw Shericka Jackson dash Sha'Carri Richardson's hopes...

A strike at Canada’s Pacific coast ports continued for a second day on Sunday as mediation efforts between